drugset / Trial / NCT06643130

Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia

NCT06643130 ↗

Phase 3 Recruiting 162 enrolled JW Pharmaceutical
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients with Hypertension and Dyslipidemia

Timeline

Start
2024-12-02
Primary completion
2026-04
Completion
2026-04

Drugs

EvaluationDrugModalityDoseRoute
Subject C2402 Unknown — Oral
Comparator C2403 Unknown — Oral
Subject JW0104 Unknown — Oral